Peptide vaccine for animal and preparation method thereof
The invention provides an aftosa synthetic peptide vaccine, more specifically to polypeptide for aftosa synthetic peptide vaccine, vaccine containing the polypeptide and a preparation method thereof. The polypeptide has amino acid sequence represented by SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3, SEQ ID...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention provides an aftosa synthetic peptide vaccine, more specifically to polypeptide for aftosa synthetic peptide vaccine, vaccine containing the polypeptide and a preparation method thereof. The polypeptide has amino acid sequence represented by SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3, SEQ ID NO.4, SEQ ID NO.5 and SEQ ID NO.6. By sequencing of recent aftosa strain in China and combination of aftosa vaccine strain sequence, the invention researches variation case of main antigen site, carries out antigen site analysis and forecast assisted by computer, and carries out chemical synthesis to possible antigen site peptide segment. The invention screens polypeptide antigen through a large amount of animal tests, optimizes aftosa virus antigen site according to screening result, effectively combines T cell epitope and B cell epitope, and enhances immunization effect of the polypeptide antigen. The aftosa synthetic peptide can effectively reply antigenic variation of the aftosa virus, has good biological safe |
---|